On March 21, MIP is hosting a one-day US Patent Forum conference to shed light on strategies for litigating at the PTAB, examine the inconsistencies between the district court and federal circuit in addressing evidence, debate whether pharma patents should be treated as a special case and more.

WilmerHale Partner Mark Selwyn will be a moderator on the panel, "Patent Trial and Appeal Board: Top Issues After Four Years," which includes WilmerHale Partner Joe Haag as a panelist. They will provide an overview of settlements from the past year to establish ongoing trends, discuss what is reviewable in institution decisions and how to challenge that decision and examine relevant cases.